Pharmaxis (ASX:PXS) and seven multinational biotechs with a presence in Australia have been short-listed for the Prix Galien UK pharmaceutical R&D awards. [ + ]

A new partnership between Monash University and Pfizer will establish the Centre for Therapeutic Innovation. [ + ]

Fifteen young Australian medical researchers are off to Germany to meet with Nobel Prize winners in physiology and medicine. [ + ]

Life Sciences Queensland (LSQ) and Bioindustrial Innovation Canada (BIC) have signed a memorandum of understanding to accelerate the commercialisation of advanced new technologies. [ + ]

AUT University has announced the opening of the AUT-Roche Diagnostics Laboratory in an example of the strong collaboration between the university and Roche Diagnostics - a partnership said to be the first of its kind in New Zealand.  [ + ]

The 2014 Rolex Awards for Enterprise were announced this week at the Royal Society in London. Initiated in 1976, the awards program recognises enterprising men and women who are using their talents and initiative to change the world. [ + ]

Researchers at CERN have found evidence for the direct decay of the Higgs boson into fermions. This comes two years after the discovery of the particle and indicates that it behaves in the way the standard model of particle physics predicts. [ + ]

Research into muscular dystrophy has revealed a dysfunction in cell communication that causes heart failure in this disease. [ + ]

pSivida (ASX:PVA) has revealed its licensee Alimera Sciences has secured Class C approval in Italy for diabetic macular oedema treatment Iluvien. [ + ]

The Victorian Government has announced the development of a new strategy to position Victoria as an internationally competitive developer of medical technology (medtech), while also providing new opportunities for the state's advanced manufacturing sector. [ + ]

Public research bodies are responsible for the largest share of patent applications related to personalised medicine internationally, Marks & Clerk research shows. [ + ]

Minomic International has moved its scientific HQ to Macquarie University Hospital, to help commercialise prostate cancer test MiSat ELISA and jointly develop new cancer screening technologies. [ + ]

Alchemia (ASX:ACL) has commenced recruitment for a clinical trial evaluating the use of HA-Irinotecan in combination with cetuximab in metastatic colorectal cancer. [ + ]

Scientists at the University of East Anglia (UEA) have discovered what they believe to be an Achilles heel in the defensive barrier which surrounds drug-resistant bacterial cells. [ + ]

LBT Innovations (ASX:LBT) has raised $1.5m through a private placement - and will seek another $1.5m in a share purchase plan - to help fund trials of its Automated Plate Assessment System. [ + ]